Related references
Note: Only part of the references are listed.Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
Migle Gabrielaite et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea
Hyeri Seok et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
Amy Coward et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Independent Predictors of Mortality for Aeromonas Necrotizing Fasciitis of Limbs: An 18-year Retrospective Study
Tsung-Yu Huang et al.
SCIENTIFIC REPORTS (2020)
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
M. Biagi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Achromobacter Infections and Treatment Options
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents When Tested against a Large Collection of Contemporary Stenotrophomonas maltophilia Isolates from Medical Centers Worldwide
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
An Overview of the Treatment of Less Common Non-Lactose-Fermenting Gram-Negative Bacteria
Hannah K. Spencer et al.
PHARMACOTHERAPY (2020)
Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)
Ana C. Gales et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance Program
Andrew S. Fuhrmeister et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence
Paraskevi C. Fragkou et al.
MICROORGANISMS (2019)
In Vitro Activity of Minocycline against US Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Species Complex, Stenotrophomonas maltophilia, and Burkholderia cepacia Complex: Results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018
Robert K. Flamm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Achromobacter spp. healthcare associated infections in the French West Indies: a longitudinal study from 2006 to 2016
Karine Marion-Sanchez et al.
BMC INFECTIOUS DISEASES (2019)
A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration
Nadim G. El Chakhtoura et al.
CLINICAL INFECTIOUS DISEASES (2017)
IV minocycline revisited for infections caused by multidrug-resistant organisms
Benjamin Colton et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections
Elizabeth Hand et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
Iain J. Abbott et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options
Mariana Castanheira et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
David J. Ritchie et al.
CLINICAL INFECTIOUS DISEASES (2014)
Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment
Winnie Ridderberg et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii
Eliahu Bishburg et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli
HS Sader et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)